Francesco Patti

96PUBLICATIONS
302CO-AUTHORS
Epidemiological modellingGene and molecular therapySemi- and unsupervised learningNanotoxicology, health and safetyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (96)

|Jul 04, 2026
Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

|Jun 02, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

|Jun 01, 2026
Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study.

|May 29, 2026
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

|Apr 10, 2026
Threshold-Dependent Discordance Between STRATIFY JCV™ and IMMUNOWELL™ Assays in Relapsing Multiple Sclerosis.

Clara Grazia Chisari, Pina Crimì, Giulio Spampinato

|Apr 01, 2026
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.

Andrea Surcinelli, Tomas Kalincik, Izanne Roos

Pageof 16

Frequent Collaborators

19 joint publications

Massimo Filippi

17 joint publications

Anneke Van Der Walt

16 joint publications

Tomas Kalincik

15 joint publications

Eleonora E Cocco